Over 1k candidates queue up for 100 nursing posts
More than 1,000 candidates from across Goa queued outside the directorate of health services for hours on Monday to try their luck at 100 contractual nursing positions. Interviews started at 10.30am, and several candidates were in line before 6am.
Pranali, 25, a nurse in a private hospital in Bicholim, said she was surprised to see so many candidates. 'When I read about job openings, I thought, at the most, there would be 200 or 300 applicants. I didn't expect such a huge number of candidates,' she said.
Alisha, 26, who worked at Manipal Hospitals, said, 'I have been here since 7.30am. My interview hasn't happened yet, but I'm tired and hungry. I'm still standing as this job is important to me, ' she said.
Candidates were either employed in private hospitals, or unemployed. Many prefer even contract govt jobs due to the better pay package. 'My monthly takeaway is less than Rs 15,000. A govt job, even if contractual, would pay me better,' said Leena Naik, who works at a private hospital at Mapusa. She applied for all govt nursing posts. According to the Periodic Labour Force Survey (PLFS) 2023-24, the unemployment rate of Goa is 8.7%, double the national average of 4.5%, with women having a staggering 16.8% rate of unemployment.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Benefits of Trading Bitcoin CFDs
IC Markets
Learn More
Undo
AAP functionaries were at the scene distributing juice and packaged water bottles to candidates. 'This is the sad state of unemployment in Goa. Candidates came from as far as Canacona for the interview. Half of them returned as they didn't get tokens. Govt must make the job interview process easier, ' said Amit Palekar, Goa AAP president.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
16 minutes ago
- Indian Express
Haryana's sex ratio improves to 907; transgender community to celebrate birth of girls in new initiative
The Haryana Government Tuesday announced that the state's sex ratio has improved to 907, as per data collected this year till July 31 – up from 899 during the corresponding period last year. In a unique initiative, the state will also rope in transgender people to celebrate the birth of girls. The figures were revealed in the weekly meeting of the State Task Force (STF) for improving sex ratio. Sudhir Rajpal, Additional Chief Secretary, Health, chairs the meeting every Tuesday as per directions issued by Arti Singh Rao, Minister for Health and Family Welfare. The meeting focused on intensifying efforts to curb illegal abortions and further improve the state's sex ratio under the 'Beti Bachao-Beti Padhao' campaign. In a unique and inclusive initiative, Rajpal directed officials to ensure that members of the transgender community visit homes where girls are born — just as they traditionally do for the birth of boys — and present a certificate of Rs 21,000 invested with the Life Insurance Corporation (LIC) under the 'Aapki Beti Hamari Beti' scheme. For this, the Haryana government will also incentivise the transgender community and a minimum amount of Rs 1,100 is proposed to be given to such individuals. 'The campaign will be run under the supervision of the concerned Chief Medical Officer (CMO) of the district,' he said, adding that the government's sustained efforts have yielded encouraging results. Emphasising the need for stringent enforcement against illegal abortions, Rajpal instructed officials to take punitive measures, including revoking the licences of doctors found to be complicit. 'Haryana is implementing reverse tracking of all Medical Termination of Pregnancy (MTP) and abortion cases beyond 12 weeks, particularly where women already have one or more daughters. In July alone, 32 FIRs (First Information Reports) were registered in suspected reverse tracking cases, leading to 32 arrests. Additionally, FIRs are under process in four more cases, and 38 notices have been issued to private hospitals and clinics for suspected violations,' Rajpal said. The additional chief secretary also issued directions for a statewide crackdown against IVF centres involved in sex-determination tests and illegal abortion practices. It was decided that all implantations through IVF must be registered under Antenatal Care (ANC) for improved surveillance. He also asked the police department to actively coordinate with Health Department teams for tracking illegal abortion centres and arresting the culprits, while also seeking a report on the progress achieved in the FIRs filed so far by next week.
Time of India
30 minutes ago
- Time of India
7 vs 9 hours of sleep: What's the ideal amount and why it might not be what you think
We've all heard it: 'Get 8 hours of sleep.' But is that really the magic number? For years, health advice has lumped 7 to 9 hours into one big category of 'normal,' leaving most of us guessing where we fall on the sleep scale. Some swear by long weekend lie-ins, while others feel sharp and energised after just seven hours. So which is actually better: 7 or 9 hours of sleep? Can too much sleep be just as risky as too little? And what does science really say about the right amount of rest for your body and brain? New research reveals that seven hours may be the sweet spot for most adults, not just for feeling fresh in the morning, but for long-term health, mental clarity, emotional balance, and even how long you live. Let's break down the science, bust a few myths, and help you figure out your own ideal sleep rhythm. Why seven hours may be the golden number A large study published in Nature Aging examined data from nearly 500,000 adults aged 38 to 73 and uncovered a clear pattern: those who consistently slept for seven hours per night performed significantly better in tests measuring cognitive function, memory, and mental health. Compared to individuals who slept either less or more, the seven-hour sleepers showed sharper attention, quicker processing speed, and more stable moods. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Brain tumor has left my son feeling miserable; please help! Donate For Health Donate Now In contrast, both short and long sleep durations were associated with reduced problem-solving skills, poorer memory recall, and higher levels of anxiety and depression. The findings suggest that even an extra hour or two of sleep beyond the seven-hour mark may not offer added benefits and could actually be linked to declines in brain function and emotional wellbeing. Even the Journal of Clinical Sleep Medicine recommends at least seven hours for adults aged 18 to 60. Consistently getting less than that has been linked to a higher risk of obesity, stroke, Type 2 diabetes, depression, heart disease, and weakened immunity. So why not nine? That's where it gets interesting. Is sleeping nine hours harmful? Not necessarily but it can be a red flag. While an occasional long sleep is fine (like after travel or illness), regularly needing more than nine hours may point to poor sleep quality or an underlying health issue. Studies have shown that long sleepers are at greater risk for: Brain fog and slower mental processing Higher levels of inflammation in the body Mood disorders, especially depression Increased mortality risk in some long-term studies In short: more sleep doesn't automatically mean better health. If you sleep longer and still feel tired, it might be time to look at your sleep hygiene or consult a doctor. What happens if you sleep less than seven? If you're used to burning the midnight oil or waking up early with only 5–6 hours of sleep, your body might be silently suffering, even if you don't feel it right away. Too little sleep, especially over time, can lead to: Weight gain and metabolic issues Poor focus, mood swings, and memory lapses Weakened immune system Higher risk of heart disease and diabetes And no, 'catching up' on the weekend doesn't fully reverse the effects of regular sleep loss. Even if you're clocking in your seven to nine hours of sleep, irregular sleep timing like sleeping at different hours every night or shifting your bedtime drastically on weekends can still wreak havoc on your health. Your body's internal clock, or circadian rhythm, thrives on routine. When that rhythm is disrupted, even the right amount of sleep may not be enough to keep your system in balance. Recent large-scale research has shown that inconsistent sleep and wake times can raise the risk of developing up to 172 different health conditions, ranging from liver damage and metabolic disorders to obesity, type 2 diabetes, and cardiovascular disease. What's more alarming is that even people who technically get enough sleep, say seven or eight hours a night, face a 26% higher risk of heart attacks and strokes if their sleep pattern is erratic. In short, consistency matters just as much as duration, and maintaining a steady sleep schedule could be one of the most underrated health habits you can build. Both 7 and 9 hours can fall into the healthy sleep range but they're not created equal. For most adults, seven hours of consistent, good-quality sleep offers the best mix of mental clarity, physical recovery, and long-term health protection. Instead of just counting hours, pay attention to how you feel, how consistently you sleep, and how well your body performs during the day. Because when it comes to sleep, it's not just about more, it's about smarter. Also read| Why women suffer more from migraines and why doctors often ignore their pain
Time of India
40 minutes ago
- Time of India
Pfizer stock soars as earnings smash expectations, and company raises outlook
PFE stock: Pfizer 's stock rose more than 2% in early trading Tuesday after the pharmaceutical giant reported stronger-than-expected earnings and raised its full-year profit forecast because of the cost-cutting efforts and solid sales of its Covid products and other key drugs, as per a CNBC report. Pfizer's Stock Soars After Raising Profit Forecast The company now expects adjusted earnings per share for 2025 to come in between $2.90 and $3.10, up from its previous guidance of $2.80 to $3, according to the report. Pfizer also maintained its 2025 revenue forecast of $61 billion to $64 billion, as reported by CNBC. Productivity Tool Zero to Hero in Microsoft Excel: Complete Excel guide By Metla Sudha Sekhar View Program Finance Introduction to Technical Analysis & Candlestick Theory By Dinesh Nagpal View Program Finance Financial Literacy i e Lets Crack the Billionaire Code By CA Rahul Gupta View Program Digital Marketing Digital Marketing Masterclass by Neil Patel By Neil Patel View Program Finance Technical Analysis Demystified- A Complete Guide to Trading By Kunal Patel View Program Productivity Tool Excel Essentials to Expert: Your Complete Guide By Study at home View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program Pfizer CFO David Denton said, 'We raised our full-year 2025 Adjusted diluted EPS guidance, demonstrating confidence in our ability to execute against our strategic priorities and deliver strong results for shareholders,' as quoted in the CNBC report. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 20 Pieces of Clothing Older Women should Avoid Learn More ALSO READ: Plastic Treaty 2025: Will world leaders finally address the $1.5 trillion health crisis in Geneva? How Pfizer Is Handling Political Pressure on Drug Prices The firm's upbeat outlook comes despite the challenges posed by US political pressure to lower drug prices, including tariffs and potential pricing reforms advocated by US president Donald Trump, as per the CNBC report. The company factored in these headwinds, along with a one-time $1.35 billion charge related to a licensing deal for its cancer treatment outside China, which will hit its third-quarter results, according to the report. Live Events Pfizer's Q2 Results Surprise Wall Street in a Big Way Investors were encouraged by Pfizer's second-quarter performance, which blew past Wall Street's expectations, as per the CNBC report. Adjusted earnings per share came in at 78 cents, which was well above the 58 cents analysts predicted, as reported by CNBC. Revenue also surged 10% year-over-year to $14.65 billion, according to the CNBC report. ALSO READ: As the July jobs report paints a grim picture, 114 companies plan layoffs in August - is yours on the list? Pfizer's Covid Products Lead Revenue Growth Behind the growth were Pfizer's Covid products, including its Comirnaty vaccine, which saw a 96% revenue increase from last year because of a larger market share and more international contracts, as per the CNBC report. The company's antiviral pill Paxlovid also posted strong sales, which rose 70% from the prior year despite fewer Covid infections worldwide, according to the CNBC report. Other drugs like Vyndaqel, used to treat heart muscle disease, as well as bladder cancer treatment Padcev and blood thinner Eliquis, contributed to the positive sales momentum, as per the report. However, the company faced headwinds from its breast cancer drug Ibrance, which saw lower US prices due to Medicare reforms and generic competition, according to the CNBC report. Pfizer's Cost-Cutting Plans to Boost Profits The second quarter results come after the firm in April increased its cost-cutting efforts, which aim to help the pharmaceutical firm recover from the rapid decline of its Covid business and stock price over the past few years, as per the report. Along with the added cuts announced in April, the company now expects to deliver around $7.7 billion in savings by the end of 2027 from two separate cost-cutting program, as reported by CNBC. FAQs What helped Pfizer's revenue grow this quarter? Mostly its Covid vaccine and antiviral pill, along with strong sales from other drugs like heart and cancer treatments, as per the CNBC report. What's Pfizer doing to cut costs? They've ramped up cost-cutting programs and expect to save about $7.7 billion by the end of 2027, as per the CNBC report.
